Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A
暂无分享,去创建一个
Simon C. Potter | C. Spencer | A. Silman | M. McCarthy | P. Deloukas | E. Zeggini | J. Marchini | D. Strachan | M. Tobin | D. Clair | D. Grozeva | N. Craddock | S. Hunt | C. Lindgren | D. Clayton | L. Cardon | A. Duncanson | D. Kwiatkowski | W. Ouwehand | N. Samani | J. Todd | J. Barrett | D. Davison | D. Easton | David Evans | A. Attwood | J. Boorman | B. Cant | Ursula Everson | Judith M. Hussey | J. Jolley | A. S. Knight | K. Koch | Elizabeth Meech | S. Nutland | C. Prowse | H. Stevens | G. Walters | N. Walker | N. Watkins | T. Winzer | W. McArdle | S. Ring | M. Pembrey | S. Caesar | K. Gordon-Smith | L. Jones | C. Fraser | E. Green | M. Hamshere | P. Holmans | V. Moskvina | I. Nikolov | A. Elkin | A. Farmer | R. Williamson | P. McGuffin | I. Ferrier | S. Ball | A. Balmforth | J. Barrett | D. Bishop | M. Iles | A. Maqbool | N. Yuldasheva | A. Hall | P. Braund | R. Dixon | M. Mangino | S. Stevens | J. Thompson | F. Bredin | M. Tremelling | M. Parkes | H. Drummond | C. Lees | E. Nimmo | J. Satsangi | S. Fisher | C. Lewis | Clive M. Onnie | N. Prescott | J. Sanderson | C. Mathew | J. Barbour | M. Mohiuddin | J. Mansfield | Fraser Cummings | D. Jewell | J. Webster | Morris J. Brown | A. Dominiczak | B. Burke | J. Gungadoo | P. Munroe | S. Newhouse | A. Onipinla | C. Wallace | M. Xue | M. Caulfield | M. Farrall | I. Bruce | S. Eyre | S. Hider | A. Hinks | S. John | C. Potter | D. Symmons | W. Thomson | B. Widmer | T. Frayling | R. Freathy | H. Lango | B. Shields | M. Weedon | A. Hattersley | G. Hitman | C. Groves | N. W. Rayner | N. Timpson | M. Newport | G. Sirugo | F. Vannberg | L. Bradbury | C. Farrar | J. Franklyn | J. Heward | M. Simmonds | S. Gough | S. Seal | M. Ban | A. Goris | S. Sawcer | A. Compston | D. Conway | M. Jallow | K. Rockett | S. Bumpstead | Amy Chaney | K. Downes | R. Gwilliam | M. Inouye | A. Keniry | R. McGinnis | S. Potter | R. Ravindrarajah | P. Whittaker | D. Withers | T. Ferreira | Joanne Pereira-Gale | Z. Su | Y. Teo | Damjan Vukcevic | D. Bentley | A. Compston | S. Nejentsev | K. Elliott | J. Ghori | G. Ribas | R. Campbell | L. Maier | Matthew Hardy | J. Howson | D. Smyth | J. Cooper | C. Todhunter | Jennifer J. Pointon | Jeffrey S. Szeszko | S. Field | P. Reynolds | Erna King | J. Masters | John S Hulme | Rebecca Bailey | C. Braga | M. Owen | I. Jones | Tariq Ahmad | G. Lathrop | G. Kirov | Jane Worthington | Mark Walker | P. Wordsworth | Andrew P. Morris | Emily J. Lyons | Niall J. Cardin | G. Breen | Bryan N. Howie | A. H. Young | P. Donnelly | A. Hill | N. Taylor | Kate L. Lee | Niall Cardin | Michael C. O’Donovan | D. A. Collier | A. Barton | Nazneen Rahman | C. Bryan | Matthew A. Brown | Andrew P Morris | Michael R. Stratton | H. Leung | Hannah Donovan | Paul D. Gilbert | D. B. Dunger | Alastair Forbes | Richard J. B. Dobson | J. Perry | Erna King | Paul R. Burton | Richard Jones | J. Connell | Emma King | Ingeleif B. Hallgrimsdottir | M. McCarthy | M. O’Donovan | M. Stratton | C. Lewis | Abiodun K Onipinla | Pamela Reynolds | Alastair Compston | M. McCarthy | C. Spencer | Catherine E. Todhunter | Simon C. Potter | A. Forbes | Andrew Keniry | Suzanne E Stevens | C. Potter | Sarah F. Field
[1] M. Stone. Cross‐Validatory Choice and Assessment of Statistical Predictions , 1976 .
[2] J. Todd,et al. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus , 1987, Nature.
[3] J. Todd,et al. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. , 1987, Nature.
[4] K. Yamagata,et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. , 1993, The Journal of clinical investigation.
[5] R. Jaenisch,et al. β2-Microglobulin–Deficient NOD Mice Do Not Develop Insulitis or Diabetes , 1994, Diabetes.
[6] M. Honeyman,et al. Analysis of Families at Risk for Insulin-Dependent Diabetes Mellitus Reveals that HLA Antigens Influence Progression to Clinical Disease , 1995, Molecular medicine.
[7] T. Utsugi,et al. Major Histocompatibility Complex Class I–Restricted Infiltration and Destruction of Pancreatic Islets by NOD Mouse-Derived β-Cell Cytotoxic CD8+ T-Cell Clones In Vivo , 1996, Diabetes.
[8] W. Klitz,et al. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. , 1996, American journal of human genetics.
[9] J. Todd,et al. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. , 1999, American journal of human genetics.
[10] J. Ilonen,et al. Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. , 2000, Diabetes.
[11] B P Koeleman,et al. Evaluation of fine mapping strategies for a multifactorial disease locus: systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21. , 2000, Human molecular genetics.
[12] J. Todd,et al. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. , 2001, Human molecular genetics.
[13] H. Erlich,et al. The HLA class I A locus affects susceptibility to type 1 diabetes. , 2002, Human immunology.
[14] D. Serreze,et al. Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. Clayton,et al. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. , 2002, American journal of human genetics.
[16] C. Liddle,et al. The histopathology of the pancreas in Type I (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom , 1986, Diabetologia.
[17] P. A. Biro,et al. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population , 1994, Diabetologia.
[18] Christophe Benoist,et al. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Drijfhout,et al. Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes , 2005 .
[20] D. Clayton,et al. Population structure, differential bias and genomic control in a large-scale, case-control association study , 2005, Nature Genetics.
[21] H. Erlich,et al. Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset. , 2005, Human immunology.
[22] J. Drijfhout,et al. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] P. Concannon,et al. Extended DR3-D6S273-HLA-B haplotypes are associated with increased susceptibility to type 1 diabetes in US Caucasians. , 2005, Tissue antigens.
[24] M. Rewers,et al. Extreme genetic risk for type 1A diabetes , 2006, Proceedings of the National Academy of Sciences.
[25] Gustavo Glusman,et al. Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden. , 2006, American journal of human genetics.
[26] R. A. Bailey,et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.
[27] High Density SNP Analysis of the MHC Region Reveals Multiple Loci for Type 1A Diabetes , 2007 .
[28] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[29] S. Snelgrove,et al. β Cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice , 2007, Proceedings of the National Academy of Sciences.
[30] K. Mossman. The Wellcome Trust Case Control Consortium, U.K. , 2008 .